Skip to main navigation Skip to search Skip to main content

JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells

  • Xinzhe Shi
  • , Bevin Franko
  • , Christine Frantz
  • , Hesham M. Amin
  • , Raymond Lai

Research output: Contribution to journal › Article › peer-review

Abstract

JSI-124 (cucurbitacin I) has been recently described as a specific inhibitor of signal transducer and activator of transcription-3 (STAT3). As STAT3 activation is pathogenetically important in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma (ALK+ ALCL), we investigated whether JSI-124 can mediate significant inhibitory effects in this cell type. In two ALK+ ALCL cell lines (Karpas 299 and SU-DHL-1), JSI-124 significantly reduced the number of viable cells to 50% of that of negative controls at a dose of 5-10 μmol/l at 24 h and 1-1.25 μmol/l at 48 h. This decrease in viability was associated with apoptosis, as confirmed by the increase in the subG0/1 fraction, poly(ADP-ribose)polymerase cleavage and expression of active caspase 3. JSI-124 decreased the phosphorylated-STAT3 and -Janus kinase-3 (JAK3) levels in a dose-dependent fashion, and these changes were coupled with significant decreases in several STAT3 downstream targets, including mcl-1, bcl-2, bcl-xL and cyclin D3. Interestingly, JSI-124 also dramatically decreased the protein levels of JAK3 and nucleophosmin (NPM)-ALK, and these effects were reversible by MG132. Our data support that JSI-124 is a potentially useful therapeutic agent for ALK+ ALCL. In addition to its role as a tyrosine kinase inhibitor, JSI-124 appears to be involved in regulating proteosome degradation for proteins such as JAK3 and NPM-ALK.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalBritish Journal of Haematology
Volume135
Issue number1
DOIs
StatePublished - Oct 2006

Keywords

  • Anaplastic large cell lymphoma
  • JSI-124
  • Janus kinase-3
  • Nucleophosmin-anaplastic lymphoma kinase
  • Signal transducer and activator of transcription-3

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells'. Together they form a unique fingerprint.

Cite this